Development of a C3 Humanized Rat as a New Model for Evaluating Novel C3 Inhibitors.

Chen, Jin Y; Zhang, Lingjun; Yang, Maojing; Hughes, Elizabeth D; Freeman, Zachary T; Saunders, Thomas L; Lin, Feng

Chen, Jin Y; Zhang, Lingjun; Yang, Maojing; Hughes, Elizabeth D; Freeman, Zachary T; Saunders, Thomas L; Lin, Feng.

Afiliación

Chen JY; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Zhang L; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Yang M; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Hughes ED; Transgenic Animal Model Core, University of Michigan, Ann Arbor, Michigan, USA.
Freeman ZT; Transgenic Animal Model Core, University of Michigan, Ann Arbor, Michigan, USA.
Saunders TL; Transgenic Animal Model Core, University of Michigan, Ann Arbor, Michigan, USA.
Lin F; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.

J Innate Immun ; 16(1): 56-65, 2024.

Article en En | MEDLINE | ID: mdl-38035563

Asunto(s)

Activación de Complemento; Hemólisis; Ratas; Humanos; Animales; Primates

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Activación de Complemento / Hemólisis Límite: Animals / Humans Idioma: En Revista: J Innate Immun Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google